Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Putting 'clear' into nuclear medicine: a decade of PET/CT development.

Literature DB >> 16794821

Putting 'clear' into nuclear medicine: a decade of PET/CT development.

Thomas Beyer, David W Townsend.

Abstract

Mesh：

Year: 2006 PMID： 16794821 DOI： 10.1007/s00259-006-0137-z

Source DB: PubMed Journal: Eur J Nucl Med Mol Imaging ISSN： 1619-7070 Impact factor: 9.236

× No keyword cloud information.

28 in total

1. Cost considerations regarding an integrated CT-PET system.

Authors: G K von Schulthess
Journal: Eur Radiol Date: 2000 Impact factor: 5.315

2. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

Authors: P Therasse; S G Arbuck; E A Eisenhauer; J Wanders; R S Kaplan; L Rubinstein; J Verweij; M Van Glabbeke; A T van Oosterom; M C Christian; S G Gwyther
Journal: J Natl Cancer Inst Date: 2000-02-02 Impact factor: 13.506

Review 3. X-ray-based attenuation correction for positron emission tomography/computed tomography scanners.

Authors: Paul E Kinahan; Bruce H Hasegawa; Thomas Beyer
Journal: Semin Nucl Med Date: 2003-07 Impact factor: 4.446

4. Comparison of 2-dimensional and 3-dimensional acquisition for 18F-FDG PET oncology studies performed on an LSO-based scanner.

Authors: Martin A Lodge; Ramsey D Badawi; Richard Gilbert; Pablo E Dibos; Bruce R Line
Journal: J Nucl Med Date: 2006-01 Impact factor: 10.057

Review 5. How much CT do we need for PEt/CT? A radiologist's perspective.

Authors: H Kuehl; G Antoch
Journal: Nuklearmedizin Date: 2005 Impact factor: 1.379

Review 6. How much intravenous contrast is needed in FDG-PET/CT?

Authors: K Strobel; C M Thuerl; T F Hany
Journal: Nuklearmedizin Date: 2005 Impact factor: 1.379

7. Combined PET/CT Imaging in Oncology. Impact on Patient Management.

Authors: P G. Kluetz; C C. Meltzer; V L. Villemagne; P E. Kinahan; S Chander; M A. Martinelli; D W. Townsend
Journal: Clin Positron Imaging Date: 2000-11

8. Image analysis in patients with cancer studied with a combined PET and CT scanner.

Authors: M Charron; T Beyer; N N Bohnen; P E Kinahan; M Dachille; J Jerin; R Nutt; C C Meltzer; V Villemagne; D W Townsend
Journal: Clin Nucl Med Date: 2000-11 Impact factor: 7.794

9. Comparison of 2-dimensional and 3-dimensional cardiac 82Rb PET studies.

Authors: J R Votaw; M White
Journal: J Nucl Med Date: 2001-05 Impact factor: 10.057

10. PET attenuation coefficients from CT images: experimental evaluation of the transformation of CT into PET 511-keV attenuation coefficients.

Authors: C Burger; G Goerres; S Schoenes; A Buck; A H R Lonn; G K Von Schulthess
Journal: Eur J Nucl Med Mol Imaging Date: 2002-04-19 Impact factor: 9.236

14 in total

Review 1. Review of functional/anatomical imaging in oncology.

Authors: Stephanie N Histed; Maria L Lindenberg; Esther Mena; Baris Turkbey; Peter L Choyke; Karen A Kurdziel
Journal: Nucl Med Commun Date: 2012-04 Impact factor: 1.690

2. Respiratory motion handling is mandatory to accomplish the high-resolution PET destiny.

Authors: Doumit Daou
Journal: Eur J Nucl Med Mol Imaging Date: 2008-09-12 Impact factor: 9.236

3. Robust automatic rigid registration of MRI and X-ray using external fiducial markers for XFM-guided interventional procedures.

Authors: Ashvin K George; Merdim Sonmez; Robert J Lederman; Anthony Z Faranesh
Journal: Med Phys Date: 2011-01 Impact factor: 4.071

Putting 'clear' into nuclear medicine: a decade of PET/CT development.

1. Cost considerations regarding an integrated CT-PET system.

2. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

Review 3. X-ray-based attenuation correction for positron emission tomography/computed tomography scanners.

4. Comparison of 2-dimensional and 3-dimensional acquisition for 18F-FDG PET oncology studies performed on an LSO-based scanner.

Review 5. How much CT do we need for PEt/CT? A radiologist's perspective.

Review 6. How much intravenous contrast is needed in FDG-PET/CT?

7. Combined PET/CT Imaging in Oncology. Impact on Patient Management.

8. Image analysis in patients with cancer studied with a combined PET and CT scanner.

9. Comparison of 2-dimensional and 3-dimensional cardiac 82Rb PET studies.

10. PET attenuation coefficients from CT images: experimental evaluation of the transformation of CT into PET 511-keV attenuation coefficients.

Review 1. Review of functional/anatomical imaging in oncology.

2. Respiratory motion handling is mandatory to accomplish the high-resolution PET destiny.

3. Robust automatic rigid registration of MRI and X-ray using external fiducial markers for XFM-guided interventional procedures.

4. PET/MR attenuation correction: where have we come from and where are we going?

Review 5. The clinical evaluation of novel imaging methods for cancer management.

6. PET characteristics of a dedicated breast PET/CT scanner prototype.

7. PET/MRI: a different spin from under the rim.

8. Is PET-CT the only option?

9. Is radionuclide transmission scanning obsolete for dual-modality PET/CT systems?

10. Optimisation of whole-body PET/CT scanning protocols.